abrdn World Healthcare Fund: Business Overview, Financials & Competitive Analysis

abrdn World Healthcare Fund Overview

abrdn World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by abrdn Inc. that invests in public equity and fixed income markets across the globe, focusing on stocks of companies operating in the healthcare sector while primarily investing in corporate debt securities for its fixed income portion. The fund focuses on global healthcare and biotech/pharmaceutical opportunities, aiming to capture long-term secular factors of demographics and innovation that will drive sector growth.

Strategic Profile

The fund invests at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industry including equity and debt securities. The fund's investment objective is to seek current income and long-term capital appreciation. The portfolio is focused on innovation-led healthcare opportunities globally while maintaining exposure to select large-cap pharmaceutical companies to balance risk, and adds to companies where value creation is driven by company-specific execution rather than broader market sentiment.

Competitive Landscape

abrdn World Healthcare Fund competes with other closed-end healthcare-focused mutual funds including abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), and abrdn Healthcare Opportunities Fund (THQ). It also competes with open-ended healthcare mutual funds and ETFs offered by major asset managers. The fund's differentiation lies in its global diversification focus, active management emphasizing innovation-led companies, and consistent monthly distribution strategy.

Industry Context

abrdn World Healthcare Fund operates in Mutual Funds.

Key facts

Founded: 2015 · Headquarters: Philadelphia, US · Revenue: $120.6M (2024)